Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
5.55
-0.25 (-4.31%)
Nov 6, 2026, 3:00 PM CST

SHA:600664 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
16,29515,96416,17615,45713,80912,802
Revenue Growth
2.22%-1.31%4.65%11.93%7.86%18.66%
Gross Profit
4,2234,1144,5214,0133,3632,976
Operating Income
840.46572.25849.71618.44557.91447.79
Net Income
633.23361.6628.85395.26465.15371.08
Earnings Per Share
0.250.140.250.160.180.15
EPS Growth
37.81%-44.00%56.25%-11.11%20.00%-

Revenue by Segment

Fiscal Year
FY 2025
Period EndingDec '25
Industrial
5,741
Business Tips
10,339
Interdepartmental Offset
-179.83
Total
15,901

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,2663,4373,6343,0602,4331,592
Total Debt
1,0631,2361,7621,8572,1492,313
Net Cash (Debt)
2,2032,2011,8721,203284.1-720.94
Net Cash Growth
47.42%17.58%55.56%323.57%--
Net Cash Per Share
0.860.850.740.490.11-0.29

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
899.38439.66792.5949.67622.09-162.44
Capital Expenditures
-175.91-150.95-100.81-86.54-89.65-76.7
Free Cash Flow
723.47288.71691.69863.14532.45-239.13
Free Cash Flow Growth
319.31%-58.26%-19.86%62.11%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
25.92%25.77%27.95%25.96%24.35%23.24%
Operating Margin
5.16%3.58%5.25%4.00%4.04%3.50%
Pretax Margin
5.36%3.59%5.41%4.21%5.08%4.93%
Profit Margin
3.89%2.27%3.89%2.56%3.37%2.90%
FCF Margin
4.44%1.81%4.28%5.58%3.86%-1.87%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
22.4624.0316.5421.3716.3424.09
Forward PE
23.1312.3212.4812.4812.4812.48
P/FCF Ratio
19.3230.1015.049.7814.27-
PS Ratio
0.860.540.640.550.550.70